Suppr超能文献

当前声带注射增强的应用实践:适应证、治疗原则、技术和并发症。

Current practice in injection augmentation of the vocal folds: indications, treatment principles, techniques, and complications.

机构信息

Department of Otorhinolaryngology, Weill Cornell Medical College, New York, New York 10021, USA.

出版信息

Laryngoscope. 2010 Feb;120(2):319-25. doi: 10.1002/lary.20737.

Abstract

OBJECTIVES/HYPOTHESIS: To identify contemporary indications, treatment principles, technique, injection materials, complications, and success rates of vocal fold injection augmentation.

STUDY DESIGN

Multi-institutional retrospective review.

METHODS

Records of patients undergoing injection augmentation at seven university medical centers from July 2007 through June 2008 were reviewed for information regarding diagnosis, unilateral or bilateral injection, route of injection, anesthesia, treatment site (office or operating room), material used, reason for technique selected, and technical success.

RESULTS

In 12 months, 460 injections were performed, 236 (51%) in awake, unsedated patients, and 224 (49%) under general anesthesia. Indications included vocal fold paralysis (248; 54%), paresis (97; 21%), atrophy (68; 15%) and scar (47; 10%). Scar was more likely to be treated in the operating room (P = .000052). In awake patients, 112 (47%) injections were performed by transcricothyroid approach, 55 (23%) by peroral approach, 49 (21%) by transthyrohyoid membrane approach, and 20 (8%) by transthyroid cartilage approach. Neither technical success rate (99% vs. 97%) nor complication rate (3% vs. 2%) differed between awake and asleep techniques. The most common materials in the clinic setting were methylcellulose (35%), bovine collagen (28%), and calcium hydroxylapatite (26%); in the operating room these were calcium hydroxylapatite (36%) and methylcellulose (35%). Calcium hydroxylapatite was more likely to be used under general anesthesia (P = .019). Five-year data show that the use of injection in the awake patient rose from 11% to 43% from 2003 to 2008.

CONCLUSIONS

Injection augmentation remains a safe, effective, and clinically practical treatment with a high rate of success, whether performed in the awake or asleep patient. The rapid adoption of awake injection over the past 5 years speaks to its clinical utility. Complication rates are low and equivalent to those under general anesthesia. Otolaryngologists continue to use a variety of techniques and materials to treat a range of conditions of glottic insufficiency.

摘要

目的/假设:确定声带注射增强的当代适应证、治疗原则、技术、注射材料、并发症和成功率。

研究设计

多机构回顾性研究。

方法

对 2007 年 7 月至 2008 年 6 月在 7 所大学医学中心接受注射增强治疗的患者的记录进行回顾,以获取有关诊断、单侧或双侧注射、注射途径、麻醉、治疗部位(办公室或手术室)、使用材料、选择技术的原因和技术成功率的信息。

结果

在 12 个月内,共进行了 460 次注射,236 次(51%)在清醒、未镇静的患者中进行,224 次(49%)在全身麻醉下进行。适应证包括声带麻痹(248 例;54%)、无力(97 例;21%)、萎缩(68 例;15%)和瘢痕(47 例;10%)。瘢痕更可能在手术室治疗(P =.000052)。在清醒患者中,112 例(47%)通过经甲状软骨入路进行注射,55 例(23%)通过经口入路,49 例(21%)通过经甲状腺舌骨膜入路,20 例(8%)通过经甲状软骨入路。清醒和睡眠技术之间的技术成功率(99%与 97%)和并发症发生率(3%与 2%)均无差异。在诊所环境中最常用的材料是甲基纤维素(35%)、牛胶原蛋白(28%)和羟基磷灰石钙(26%);在手术室中,这些材料是羟基磷灰石钙(36%)和甲基纤维素(35%)。羟基磷灰石钙更有可能在全身麻醉下使用(P =.019)。5 年数据显示,2003 年至 2008 年,清醒患者注射的使用率从 11%上升至 43%。

结论

无论在清醒还是睡眠患者中进行,声带注射增强仍然是一种安全、有效且具有临床实用性的治疗方法,成功率高。在过去 5 年中,清醒注射的迅速采用证明了其临床实用性。并发症发生率低,与全身麻醉相当。耳鼻喉科医生继续使用各种技术和材料来治疗各种声带功能不全。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验